Navigation Links
Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test
Date:1/15/2014

Westlake Village, Calif. (PRWEB) January 15, 2014

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the genomic analysis of tumor cells in the bloodstream, today announced that it will offer Therapy Finder™, a web-based cancer decision support application powered by CollabRx, Inc.

Available as a reporting option with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast cancer patients and their physicians with a dynamic resource to navigate and understand both the current standard of care as well as cutting edge experimental therapy options with the goal of enabling patients to receive the best possible care. ClearID customers will gain access to focused news and patient-oriented educational material on advances in breast cancer, the latest medical and scientific research, risk factors for recurrence, monitoring, and early detection. The breast cancer Therapy Finder is dynamically updated and curated by CollabRx medical and scientific personnel with the support of an editorial board composed of independent breast cancer clinical experts. The Therapy Finder for Breast Cancer is the most recent electronic decision support application released by CollabRx and complements existing Therapy Finders for lung cancer, colorectal cancer, and melanoma. It is the first such app developed specifically for a patient user.

ClearID is Cynvenio’s monitoring test for breast cancer survivors at high risk of disease recurrence. It analyzes DNA from tumor cells in the bloodstream for cancer-associated genomic mutations which can be used to characterize disease status and available treatment options. Through the partnership with CollabRx, clinicians and researchers ordering ClearID tests from Cynvenio will also have the option of requesting genomic reporting via the Genetic Variant Annotation (GVA) ServiceTM which provides clinically actionable and dynamically upda
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cynvenio Biosystems to Present Clinical Data on Mutational Analysis of LiquidBiopsy® Tumor Samples at the 2013 ASCO Annual Meeting
2. Cynvenio Biosystems Receives CLIA Certification for its Genomic Sequencing Laboratory
3. Cynvenio and CollabRx Announce Partnership for Cancer Molecular Diagnostics
4. Fortis Offers Bachelor of Science in Nursing Degree Program to Florida Students
5. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
6. UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
7. Butamax Granted Core Patent for Making Biobutanol and Distillers Grains; Offers Producers Efficient, Low-Cost Production of Biobutanol
8. Big Saver: Molderizer Offers 30% Mold Remediation Products Price Cut
9. Tri-Valley Sedation Dentist Dr. Endre Selmeczy Now Offers High-quality Dental Restorations
10. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
11. Salimetrics Offers New Saliva Collection Aid for Easy Collection of Passive Drool Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... (PRWEB) October 24, 2014 Today, Nerium ... announced the winners of its “Reflect Your Youth” contest, ... not only seen a difference in their skin since ... a new outlook on life as a result of ... originated as an effort by Nerium International to inspire ...
(Date:10/25/2014)... NEW YORK , Oct. 24, 2014 ... Access Pharmaceuticals, Inc. (ACCP), a biopharmaceutical company advancing ... implemented a 1-for-50 reverse split of its common ... Friday, October 24, 2014. PlasmaTech,s common stock will ... number 72754H109 and temporary ticker symbol "ACCPD". After ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... growth in the in vitro diagnostic (IVD) test industry, ... Kalorama Information. The healthcare market researcher listed more than 25 ... that could be the future of IVD products. Kalorama details ... industry, The Worldwide Market for In Vitro Diagnostic ...
(Date:10/22/2014)... Shimadzu Scientific Instruments introduces its Open ... the pain management and clinical markets. The software increases ... by allowing users to highlight and review results that ... allows analysts to filter results by group or based ... eliminating the need to sift through analytes of no ...
Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2Report: Radical New IVD Test Approaches Key To Growth 2Report: Radical New IVD Test Approaches Key To Growth 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2
... reduced and Semen Sexing Technology achieves, milestone, ... months ended June 30, 2009, Microbix Biosystems Inc. (TSX:MBX) announced ... quarter had a small sales retraction that was related to ... for continued growth in sales. , "The 22% sales growth ...
... , , ... SIAL ) today announced the acquisition of cheminformatics ... informatics software tools used for design, selection and procurement ... www.chemnavigator.com ) comprehensive suite of virtual screening ...
... , , , , ... SQNM ), today reported its financial results for the quarter ended June ... Second Quarter Results , , ... $12.8 million for the second quarter of 2008. The decrease from the comparable ...
Cached Biology Technology:Microbix Sales Grow 22% For Nine Months 2Microbix Sales Grow 22% For Nine Months 3Microbix Sales Grow 22% For Nine Months 4Microbix Sales Grow 22% For Nine Months 5Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services 2Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 10
(Date:10/18/2014)... referred for evaluation of suspected genetic conditions, whole-exome ... percent, including detection of a number of rare ... according to a study appearing in JAMA ... with the American Society of Human Genetics annual ... coding regions of thousands of genes simultaneously using ...
(Date:10/17/2014)... available in German . ... few drugs. When treating overdoses, doctors are often limited to ... if there is a combination of drugs involved. So what ... swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from the ... an answer to this question. "The task was to develop ...
(Date:10/16/2014)... they are anything but sustainable: environmental damage to ... becoming increasingly evident. Despite their disadvantages, however, monocultures ... as the sole possibility of achieving higher yields ... Schmid, an ecology professor at the University of ... and forestry. After all, a new study carried ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... ancient genes, scientists have for the first time reconstructed ... system. , The research was led by Joe Thornton, ... Center for Ecology and Evolutionary Biology, and will be ... How natural selection can drive the evolution of complex ...
... them study endangered whales ?autonomous hydrophones that can be deployed ... calls of different whale species. , Those efforts are leading ... of researchers of rare right whales swimming in the Gulf ... of a right whale in the Gulf of Alaska since ...
... generation of artificial bone may rely on a few ... of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have ... scaffolding-like material that is four times stronger than material ... the investigational stages, variations of this substance could also ...
Cached Biology News:Evolution of 'irreducible complexity' explained 2Research tracks whales by listening to sounds 2Research tracks whales by listening to sounds 3Secrets of the sea yield stronger artificial bone 2Secrets of the sea yield stronger artificial bone 3Secrets of the sea yield stronger artificial bone 4
... Extracts are optimized for maximum packaging efficiencies ... high efficiency extracts (> 109 pfu/g with ... a library containing at least 5 ... extracts are made from a specially designed ...
... 6 delivers enhanced statistics and statistical ... quality improvement managers. As an accepted ... 6 simplifies statistics for novice users ... by experts. It offers a powerful ...
... Mouse anti-Yersinia pestis F1 antigen, Monoclonal ... ELISA: Use at an ... an assay dependent dilution. WB: Use ... molecular weight: 18 kDa. Not tested ...
...
Biology Products: